Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2909
Selected: 0
NCT IDTitle
NCT00839683Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects
NCT01042977Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
NCT00983957Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
NCT03601611Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
NCT00976495Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes
NCT00886795Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy
NCT05779592A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma
NCT03566264Study of the Sudden Heart Failure Participant Population in the US
NCT05715463Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
NCT00284804A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
NCT03409198Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer
NCT00924898Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
NCT00412984Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
NCT04205409Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies
NCT06476821A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of Single Doses of BMS-986435 (MYK-224) in Healthy Chinese Participants
NCT02481830Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer
NCT05002569A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma
NCT03808441CAcTUS - Circulating Tumour DNA Guided Switch
NCT02401854Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder
NCT03829722Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
NCT00084253Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients
NCT03143153A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin
NCT01250366Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects
NCT03670056Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy
NCT03599622An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
NCT00203931Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
NCT02413372A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
NCT00460954A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
NCT05939700Mavacamten Pregnancy Surveillance Program
NCT00770302Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin
NCT07063745A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
NCT00028301Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
NCT04141254Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism.
NCT03605719Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
NCT06997029A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
NCT00326729Fluid Shifts During Resuscitation: Impacts on Macrocirculation and Microcirculation
NCT01120457First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
NCT05558319NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
NCT03958383IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma
NCT00365612Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients
NCT01885598Eliquis Regulatory Post Marketing Surveillance
NCT04667663CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
NCT03256136Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC
NCT00940771Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
NCT01448044Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
NCT00855764Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer
NCT02636036Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors
NCT00501644Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
NCT01850004Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response
NCT00258921RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment